08 Jul 2021 --- Kerry Group is acquiring Biosearch Life for €126.9 million (US$150 million) to expand its portfolio of health ingredients, such as probiotics and omega 3s. The move will further boost Kerry’s capabilities within functional foods and proactive health ingredients. “Biosearch is a strong complement to our portfolio and brings leading clinical research capabilities and functional food technologies across multiple life stages and need states,” Edmond Scanlon, CEO of Kerry, tells NutritionInsight.
